September 22, 2025
Photo Credit: Getty Images
SYDNEY, Australia — The International Myopia Institute (IMI) has officially published its 2025 Digest in Investigative Ophthalmology & Visual Science (IOVS). The IMI Digests provide targeted updates on topics covered in earlier white papers, equipping clinicians with current, evidence-based guidance.
The IMI provides biennial white papers to offer evidence-based consensus guidance that is both scientifically rigorous and clinically practical. The Digests offer targeted updates on topics from earlier white papers. The 2025 Digest presents focused updates in six areas: definitions and classification of myopia, clinical management guidelines, risk factors, accommodation and binocular vision, experimental models, and onset and progression in young adults.
The IMI 2025 Digest emphasizes earlier identification and prevention, particularly through assessing hyperopic reserve and promoting outdoor time. Evidence supports proactive, individualized myopia management with safe, effective optical interventions. Accommodative and binocular vision effects of myopia control are minimal. Experimental models highlight new light-mediated and molecular mechanisms, and data confirm that some young adults, especially high myopes, continue to progress. Together, these updates reinforce a proactive, lifelong approach to myopia care.
“The IMI Digest is about making science practical,” said Nina Tahhan, PhD, MPH, GradCertOcTher, BOptom(hons), Executive Director, International Myopia Institute.
“By bringing together the latest evidence in a clear and accessible way, we aim to support eye care professionals worldwide in delivering proactive, lifelong myopia care.”
A clinical summary of the paper is available on the IMI website here.
For free access to the full paper, click here.
